These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 35932416)
1. New Developments in Glucagon Treatment for Hypoglycemia. Story LH; Wilson LM Drugs; 2022 Jul; 82(11):1179-1191. PubMed ID: 35932416 [TBL] [Abstract][Full Text] [Related]
2. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality? Pontiroli AE; Ceriani V Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Usability of Intranasal Glucagon for the Management of Hypoglycemia in Patients With Diabetes: A Systematic Review. Singh-Franco D; Moreau C; Levin AD; Rosa D; Johnson M Clin Ther; 2020 Sep; 42(9):e177-e208. PubMed ID: 32873417 [TBL] [Abstract][Full Text] [Related]
6. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. La Sala L; Pontiroli AE Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638984 [TBL] [Abstract][Full Text] [Related]
8. Glucagon: Delivery advancements for hypoglycemia management. Kumar S; Sanap SN; Pandey P; Khopade A; Sawant KK Int J Pharm; 2024 Mar; 652():123785. PubMed ID: 38224759 [TBL] [Abstract][Full Text] [Related]
9. Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes. Sherr JL; Ruedy KJ; Foster NC; Piché CA; Dulude H; Rickels MR; Tamborlane WV; Bethin KE; DiMeglio LA; Fox LA; Wadwa RP; Schatz DA; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW; Diabetes Care; 2016 Apr; 39(4):555-62. PubMed ID: 26884472 [TBL] [Abstract][Full Text] [Related]
10. Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study. Yale JF; Dulude H; Egeth M; Piché CA; Lafontaine M; Carballo D; Margolies R; Dissinger E; Shames AR; Kaplowitz N; Zhang MX; Zhang S; Guzman CB Diabetes Technol Ther; 2017 Jul; 19(7):423-432. PubMed ID: 28556672 [TBL] [Abstract][Full Text] [Related]
11. Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies. Lowe RN; Trujillo JM Ann Pharmacother; 2020 Aug; 54(8):780-787. PubMed ID: 32052651 [No Abstract] [Full Text] [Related]
12. Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model. Hinahara J; Weinzimer SA; Bromley ER; Goss TF; Kendall DM; Hammer M J Manag Care Spec Pharm; 2022 Apr; 28(4):461-472. PubMed ID: 35332789 [No Abstract] [Full Text] [Related]
13. Pharmacology Update: Emergency Medications for Hypoglycemia in Diabetes. Schaumleffel C NASN Sch Nurse; 2021 May; 36(3):149-154. PubMed ID: 33487097 [TBL] [Abstract][Full Text] [Related]
14. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus. Stenninger E; Aman J Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872 [TBL] [Abstract][Full Text] [Related]
15. Intranasal glucagon: a promising approach for treatment of severe hypoglycemia. Pontiroli AE J Diabetes Sci Technol; 2015 Jan; 9(1):38-43. PubMed ID: 25385946 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia. Pontiroli AE; Tagliabue E Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349701 [TBL] [Abstract][Full Text] [Related]
17. Novel Preparations of Glucagon for the Prevention and Treatment of Hypoglycemia. Hawkes CP; De Leon DD; Rickels MR Curr Diab Rep; 2019 Sep; 19(10):97. PubMed ID: 31493043 [TBL] [Abstract][Full Text] [Related]
18. Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting. Seaquist ER; Dulude H; Zhang XM; Rabasa-Lhoret R; Tsoukas GM; Conway JR; Weisnagel SJ; Gerety G; Woo VC; Zhang S; Carballo D; Pradhan S; Piché CA; Guzman CB Diabetes Obes Metab; 2018 May; 20(5):1316-1320. PubMed ID: 29504662 [TBL] [Abstract][Full Text] [Related]
19. Glucagon: Its evolving role in the management of hypoglycemia. Isaacs D; Clements J; Turco N; Hartman R Pharmacotherapy; 2021 Jul; 41(7):623-633. PubMed ID: 33963599 [TBL] [Abstract][Full Text] [Related]
20. A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting. Deeb LC; Dulude H; Guzman CB; Zhang S; Reiner BJ; Piché CA; Pradhan S; Zhang XM Pediatr Diabetes; 2018 Aug; 19(5):1007-1013. PubMed ID: 29512902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]